HbA1c, Coronary atheroma progression and cardiovascular outcomes

BACKGROUND AND AIMS: We tested the hypothesis that on-treatment HbA1c levels independently associate with coronary atheroma progression and major adverse cardiovascular events (MACE: death, myocardial infarction, cerebrovascular accident, coronary revascularization, or hospitalization for unstable a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dykun, Iryna, Bayturan, Ozgur, Carlo, Julie, Nissen, Steven E., Kapadia, Samir R., Tuzcu, E. Murat, Nicholls, Stephen J., Puri, Rishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790601/
https://www.ncbi.nlm.nih.gov/pubmed/35112095
http://dx.doi.org/10.1016/j.ajpc.2022.100317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790601/
https://www.ncbi.nlm.nih.gov/pubmed/35112095
http://dx.doi.org/10.1016/j.ajpc.2022.100317

Ejemplares similares